| PERIOD ENDING | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 3,164,000 | 3,028,000 | 3,340,000 | 3,349,000 | | Cost of Revenue | 1,960,000 | 1,886,000 | 2,143,000 | 2,109,000 | | | Gross Profit | 1,204,000 | 1,142,000 | 1,197,000 | 1,240,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 870,000 | 864,000 | 1,017,000 | 1,041,000 | | Non Recurring | 269,000 | 16,000 | 147,000 | (154,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 65,000 | 262,000 | 33,000 | 353,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 11,000 | 6,000 | 21,000 | | Earnings Before Interest And Taxes | 72,000 | 273,000 | 39,000 | 374,000 | | Interest Expense | 38,000 | 45,000 | 41,000 | 46,000 | | Income Before Tax | 34,000 | 228,000 | (2,000) | 328,000 | | Income Tax Expense | 48,000 | 63,000 | 15,000 | 98,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,000) | 165,000 | (17,000) | 230,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,000) | 165,000 | (17,000) | 230,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,000) | $165,000 | ($17,000) | $230,000 |
|
2.03% Nasdaq 0.00%
Income Statement
